Benchmark Maintains a 'Buy' on Synergetics USA (SURG); Recent Dip Offers Opportunity
Tweet Send to a Friend
Benchmark maintains a 'Buy' on Synergetics USA (NASDAQ: SURG) price target of $8.00.
Analyst, Raymond Myers, said, "Meeting with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Raymond Myers, said, "Meeting with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
